Panbela Therapeutics PBLA

$ 1.1 -10.56%

Quarterly report 2024-Q3
added 11-14-2024

Panbela Therapeutics Cash and Cash Equivalents 2011-2024 | PBLA

Annual Cash and Cash Equivalents Panbela Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.58 M	1.28 M	11.9 M	9.02 M	2.45 M	1.4 M	152 K	438 K	925 K	1.65 M	58.8 K	111 K	47.9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.9 M	47.9 K	2.46 M

Quarterly Cash and Cash Equivalents Panbela Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
142 K	59 K	262 K	2.58 M	907 K	7.2 M	5.24 M	1.28 M	941 K	2.53 M	7.39 M	11.9 M	14.1 M	6.4 M	8.1 M	9.02 M	9.02 M	9.02 M	9.02 M	2.45 M	2.45 M	2.45 M	2.45 M	1.4 M	1.4 M	1.4 M	1.4 M	152 K	152 K	152 K	152 K	438 K	438 K	438 K	438 K	925 K	925 K	925 K	925 K	1.65 M	1.65 M	164 K	164 K	2.69 M	58.8 K	58.8 K	58.8 K	111 K	111 K	111 K	111 K	47.9 K	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.1 M	47.9 K	2.57 M